Repligen | Lucro Operacional

Preço das Ações
134.78
Mudança Diária
-3.33 -2.41%
Mensal
-17.48%
Anual
-17.15%
Q1 Previsão
132.21




Lucro Operacional Alterar Data
Agilent USD 443M 66M 2025-09
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 512M 401M 2025-09
Exact Sciences USD -25M 22.85M 2025-09
General Electric Aerospace USD 1.77B 536M 2025-12
Henry Schein USD 198M 22M 2025-09
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
OraSure Technologies USD -6M 3.26M 2024-09
Pacific Biosciences Of California USD -64.08M 111.77M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
Repligen USD 12.68M 6.72M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Standard Biotools USD -23.47M 230K 2025-09
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12
West Pharmaceutical Services USD 162.5M 5.1M 2025-12


Repligen Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.